<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03325855</url>
  </required_header>
  <id_info>
    <org_study_id>AmericanGA</org_study_id>
    <nct_id>NCT03325855</nct_id>
  </id_info>
  <brief_title>Fecal Microbiota Transplant National Registry</brief_title>
  <acronym>FMT</acronym>
  <official_title>Fecal Microbiota Transplant National Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American Gastroenterological Association</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>OpenBiome</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>American Gastroenterological Association</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A national data registry of patients receiving fecal microbiota transplantation (FMT) or
      other gut-related-microbiota products designed to prospectively assess short and long-term
      safety and effectiveness
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This registry will prospectively enroll 4,000 patients who undergo FMT at 75 sites throughout
      North America. Information on FMT methodology employed (e.g., screening of donor and
      recipient, preparation, FMT delivery) will be collected from each site. The indication for
      FMT as well as baseline information on recipient will also be collected. Following FMT,
      patients will be followed at regular intervals up to 10 years post FMT. This will include
      follow-up information from the patient's healthcare provider at 1 month, 6 months, 1 year,
      and 2 years after FMT as well as direct communication with patients at least annually up to
      10 years after FMT. Follow-up information collected will be designed to assess potential
      short-term and long-term safety and effectiveness.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 20, 2017</start_date>
  <completion_date type="Anticipated">August 2026</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Occurrence of treatment related Adverse Events</measure>
    <time_frame>over 10 Years</time_frame>
    <description>Adverse events to be monitored include surgeries, infection, hospitalization, other life-threatening events, death and newly diagnosed diseases.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease Re-occurrence Following FMT</measure>
    <time_frame>over 10 Years</time_frame>
    <description>Assess effectiveness of FMT by monitoring disease re-occurrence post treatment.</description>
  </primary_outcome>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Fecal Microbiota Transplantation</condition>
  <condition>Clostridium Difficile Infection</condition>
  <condition>Gut Microbiome</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>None - Observational</intervention_name>
    <description>None - Observational</description>
    <other_name>Observational</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients receiving FMT or other gut-related-microbiota products and the donors
        providing specimens for the enrolled patients' FMT. Patients will be enrolled regardless of
        race, gender, ethnicity, or age.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recipient Inclusion Criteria

               -  Ability to give informed consent

               -  Receiving FMT or other gut-related microbiota product within 90 days after
                  providing consent

               -  Access to internet and/or telephone

          -  Donor Inclusion

               -  Ability to give informed consent

               -  Providing stool sample for FMT

        Exclusion Criteria:

          -  Incarceration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sonya Serra, MSc</last_name>
    <phone>3019412616</phone>
    <email>sserra@gastro.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yanina Nersesova, MA</last_name>
    <phone>3019412600</phone>
    <email>ynersesova@gastro.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital of Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roy Leong, CCRP</last_name>
    </contact>
    <investigator>
      <last_name>Sonia Michail, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sutter Roseville Medical Center</name>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <zip>95661</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Hsu, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Ronald Hsu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale New Haven Hospital</name>
      <address>
        <city>Hamden</city>
        <state>Connecticut</state>
        <zip>06518</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Candace Cotto, RN</last_name>
    </contact>
    <investigator>
      <last_name>Paul Feuerstadt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NorthShore University Health System</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edessa David</last_name>
    </contact>
    <investigator>
      <last_name>Eugene Yen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carle Foundation Hospital</name>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Canfield, BS, CCRP</last_name>
    </contact>
    <investigator>
      <last_name>Lyn Tangen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University School of Medicine</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmalee Phelps</last_name>
    </contact>
    <investigator>
      <last_name>Monika Fischer, M.D., MSc.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>American Gastroenterological Association</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20814</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>McKenzie Leier</last_name>
    </contact>
    <investigator>
      <last_name>Stacy Kahn, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edina Shu</last_name>
    </contact>
    <investigator>
      <last_name>Jessica Allegretti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Kammer</last_name>
    </contact>
    <investigator>
      <last_name>Sahil Khanna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josephine Mitcham</last_name>
    </contact>
    <investigator>
      <last_name>Ari Grinspan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastroenterology Group of Rochester, LLP</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14618</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Lawatsch</last_name>
    </contact>
    <investigator>
      <last_name>Jonathan Goldstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brown University Women's Medicine and Collaborative</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02904</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrizia Curran</last_name>
    </contact>
    <investigator>
      <last_name>Colleen Kelly, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2017</study_first_submitted>
  <study_first_submitted_qc>October 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2017</study_first_posted>
  <last_update_submitted>April 10, 2018</last_update_submitted>
  <last_update_submitted_qc>April 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>FMT</keyword>
  <keyword>CDI</keyword>
  <keyword>Fecal Matter Transplant</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

